RGS21 Inhibitors

Chemical inhibitors of Regulator of G-protein signaling 21 (RGS21) act through various mechanisms to impede its function within cellular signaling pathways. Pertussis Toxin operates by ADP-ribosylating and inhibiting Gi/o proteins which are critical for the modulation of G-protein-coupled receptor (GPCR) signaling. In normal conditions, RGS21 would enhance the intrinsic GTPase activity of these Gi/o proteins, hastening their transition to an inactive state, but in the presence of Pertussis Toxin, the availability of Gi/o proteins for RGS21 to act upon is diminished, leading to an inhibition of RGS21 function. Similarly, NF 023 targets P2X purinoceptor antagonism and can indirectly inhibit RGS21 by reducing the pool of G-proteins available for interaction and regulation. U-73122, on the other hand, inhibits downstream signaling by targeting phospholipase C (PLC), thereby potentially limiting the signaling cascade in which RGS21 is involved.

Additional inhibitors exert their effects by influencing various aspects of G-protein signaling. Cholera Toxin permanently activates the Gs alpha subunit, leading to continuous cAMP production, which can indirectly reduce the regulator's interaction with G-alpha subunits, resulting in a functional inhibition of RGS21. Clostridium botulinum C3 exoenzyme inactivates Rho GTPases, which can affect the signaling pathways governed by RGS21, while ML 141 specifically inhibits Cdc42 GTPase, potentially altering actin cytoskeleton and membrane trafficking that support G-protein signaling involving RGS21. Go 6983 inhibits protein kinase C (PKC) which is responsible for the phosphorylation of certain proteins in signaling pathways that RGS21 is known to regulate. Suramin antagonizes P2 purinergic receptors, leading to a decrease in G-protein-mediated signaling and an inhibition of RGS21's regulatory role. Lastly, SecinH3 targets cytohesins, disrupting ARF-mediated G-protein signaling, and consequently, the modulation of these pathways by RGS21.